Funding for this research was provided by:
Merck (MISP #52933 PEMDAC)
Syndax Pharmaceuticals (SDX-1953)
Text and Data Mining valid from 2019-05-02
Received: 19 November 2018
Accepted: 18 April 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: The study is approved by the regional Ethics Board of Gothenburg, approval number 692–16. Signed and dated informed consent will be obtained from each patient in accordance with the principles of ICH-GCP and the latest version of the Declaration of Helsinki.
: Not applicable.
: ROB, GU, IL, US, ML and LN have had a paid consulting or advisory role with MSD, Sweden. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.